QA: Insmed Inc in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001104506_2014_Insmed_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'0020 - Statement - Consolidated Statements of Comprehensive Loss': 16, '0021 - Statement - Consolidated Statements of Comprehensive Loss (Calc 2)': 2}}

Graph

Absolute values for 0001104506, Insmed Inc

  xvar xval
0 AssetsCurrent 116,163,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,812,000
3 remainder_Assets 58,523,000
4 LiabilitiesCurrent 16,456,000
5 LiabilitiesNoncurrent 16,338,000
6 remainder_Liabilities 380,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 22,236,000
9 ResearchAndDevelopmentExpense 44,279,000
10 remainder_Expenses 1,191,000
11 remainder_Revenues 11,500,000
12 remainder_NetIncome 133,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 176,498,000
1 Liabilities 33,174,000
2 Expenses 67,706,000
3 Revenues 11,500,000
4 StockholdersEquity 143,324,000
5 NetIncome -56,073,000
6 ComprehensiveNetIncome -56,073,000
7 BaseVar 144,505,500
8 EconomicCapitalRatiobeforeLimitedLiability 2.45
9 EconomicCapitalRatio 3.32

Edgar->Model Mapping

Feature Distribution